Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Tratamiento con agonista dopaminérgico en la enfermedad de Parkinson precoz

Information

DOI:
https://doi.org/10.1002/14651858.CD006564.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 23 April 2008see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:

  1. Cochrane Movement Disorders Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Rebecca Stowe

    Correspondence to: University of Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK

    [email protected]

  • Natalie Ives

    University of Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK

  • Carl E Clarke

    Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK

  • van Hilten

    Department of Neurology, Leiden University of Medical Center, Leiden, Netherlands

  • Joaquim Ferreira

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Robert J Hawker

    University of Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK

  • Laila Shah

    University of Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK

  • Keith Wheatley

    Birmingham Clinical Trials Unit ‐ Division of Medical Sciences, Robert Aitken Institute University of Birmingham, Birmingham, UK

  • Richard Gray

    Clinical Trials Unit, The University of Birmingham, Edgbaston, UK

Contributions of authors

Rebecca Stowe contributed to the design of the protocol and was involved in data extraction, analysis and interpretation for the review
Natalie Ives contributed to the design of the protocol and was involved in data extraction, analysis and interpretation for the review
Carl Clarke contributed to the design of the protocol and was involved in analysis and interpretation for the review
JJ Van Hilten contributed to the design of the protocol and was involved in data extraction, analysis and interpretation for the review
Joaquim Ferreira contributed to the design of the protocol and was involved in data extraction, analysis and interpretation for the review
Laila Shah contributed to data extraction for the review
Robert Hawker contributed to data extraction for the review
Keith Wheatley contributed to the design of the protocol and was involved in analysis and interpretation for the review
Richard Gray contributed to the design of the protocol and was involved in analysis and interpretation for the review

Declarations of interest

CE Clarke has received payments from the manufacturers of several of the drugs discussed for consultancy, lecture fees and travel.

Acknowledgements

We recognise the contribution of all the original trial teams and the individuals who performed the trials that contributed to this meta‐analysis, and thank the patients who agreed to help improve Parkinson's disease treatment by taking part in these trials.

Version history

Published

Title

Stage

Authors

Version

2008 Apr 23

Dopamine agonist therapy in early Parkinson's disease

Review

Rebecca Stowe, Natalie Ives, Carl E Clarke, van Hilten, Joaquim Ferreira, Robert J Hawker, Laila Shah, Keith Wheatley, Richard Gray

https://doi.org/10.1002/14651858.CD006564.pub2

2007 Apr 18

Dopamine agonist therapy in early Parkinson's disease

Protocol

Rebecca Stowe, Natalie Ives, Carl E Clarke, JJ van Hilten, Joaquim Ferreira, Robert J Hawker, Laila Shah, Keith Wheatley, Richard Gray

https://doi.org/10.1002/14651858.CD006564